Design, synthesis, and biological evaluation of multiple targeting antimalarials
Malaria still threatens global health seriously today. While the current discoveries of antimalarials are almost totally focused on single mode-of-action inhibitors, multi-targeting inhibitors are highly desired to overcome the increasingly serious drug resistance. Here, we performed a structure-bas...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-09-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221138352100174X |
| _version_ | 1818719770729512960 |
|---|---|
| author | Yiqing Yang Tongke Tang Xiaolu Li Thomas Michel Liqin Ling Zhenghui Huang Maruthi Mulaka Yue Wu Hongying Gao Liguo Wang Jing Zhou Brigitte Meunier Hangjun Ke Lubin Jiang Yu Rao |
| author_facet | Yiqing Yang Tongke Tang Xiaolu Li Thomas Michel Liqin Ling Zhenghui Huang Maruthi Mulaka Yue Wu Hongying Gao Liguo Wang Jing Zhou Brigitte Meunier Hangjun Ke Lubin Jiang Yu Rao |
| author_sort | Yiqing Yang |
| collection | DOAJ |
| description | Malaria still threatens global health seriously today. While the current discoveries of antimalarials are almost totally focused on single mode-of-action inhibitors, multi-targeting inhibitors are highly desired to overcome the increasingly serious drug resistance. Here, we performed a structure-based drug design on mitochondrial respiratory chain of Plasmodium falciparum and identified an extremely potent molecule, RYL-581, which binds to multiple protein binding sites of P. falciparum simultaneously (allosteric site of type II NADH dehydrogenase, Qo and Qi sites of cytochrome bc1). Antimalarials with such multiple targeting mechanism of action have never been reported before. RYL-581 kills various drug-resistant strains in vitro and shows good solubility as well as in vivo activity. This structure-based strategy for designing RYL-581 from starting compound may be helpful for other medicinal chemistry projects in the future, especially for drug discovery on membrane-associated targets. |
| first_indexed | 2024-12-17T20:12:14Z |
| format | Article |
| id | doaj.art-758bd29995144fb9bf6cbdfaf5de897f |
| institution | Directory Open Access Journal |
| issn | 2211-3835 |
| language | English |
| last_indexed | 2024-12-17T20:12:14Z |
| publishDate | 2021-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj.art-758bd29995144fb9bf6cbdfaf5de897f2022-12-21T21:34:13ZengElsevierActa Pharmaceutica Sinica B2211-38352021-09-0111929002913Design, synthesis, and biological evaluation of multiple targeting antimalarialsYiqing Yang0Tongke Tang1Xiaolu Li2Thomas Michel3Liqin Ling4Zhenghui Huang5Maruthi Mulaka6Yue Wu7Hongying Gao8Liguo Wang9Jing Zhou10Brigitte Meunier11Hangjun Ke12Lubin Jiang13Yu Rao14MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, ChinaUnit of Human Parasite Molecular and Cell Biology, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, ChinaDepartment of Biochemistry and Molecular Biology, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100005, ChinaInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, Gif-sur-Yvette 91198, FranceCenter for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19129, USA; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, ChinaUnit of Human Parasite Molecular and Cell Biology, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; The Nanjing Unicorn Academy of Innovation, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Nanjing 211135, ChinaCenter for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19129, USAMOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, ChinaMOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, ChinaMOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, ChinaDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, ChinaInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, Gif-sur-Yvette 91198, FranceCenter for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19129, USAUnit of Human Parasite Molecular and Cell Biology, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; The Nanjing Unicorn Academy of Innovation, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Nanjing 211135, China; Corresponding authors. Tel./fax: +86 10 62782025 (Yu Rao), +86 21 54923072 (Lubin Jiang).MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing 100084, China; Corresponding authors. Tel./fax: +86 10 62782025 (Yu Rao), +86 21 54923072 (Lubin Jiang).Malaria still threatens global health seriously today. While the current discoveries of antimalarials are almost totally focused on single mode-of-action inhibitors, multi-targeting inhibitors are highly desired to overcome the increasingly serious drug resistance. Here, we performed a structure-based drug design on mitochondrial respiratory chain of Plasmodium falciparum and identified an extremely potent molecule, RYL-581, which binds to multiple protein binding sites of P. falciparum simultaneously (allosteric site of type II NADH dehydrogenase, Qo and Qi sites of cytochrome bc1). Antimalarials with such multiple targeting mechanism of action have never been reported before. RYL-581 kills various drug-resistant strains in vitro and shows good solubility as well as in vivo activity. This structure-based strategy for designing RYL-581 from starting compound may be helpful for other medicinal chemistry projects in the future, especially for drug discovery on membrane-associated targets.http://www.sciencedirect.com/science/article/pii/S221138352100174XDrug designMultiple targeting compoundsAntimalarial inhibitorsMechanism of actionMembrane proteins |
| spellingShingle | Yiqing Yang Tongke Tang Xiaolu Li Thomas Michel Liqin Ling Zhenghui Huang Maruthi Mulaka Yue Wu Hongying Gao Liguo Wang Jing Zhou Brigitte Meunier Hangjun Ke Lubin Jiang Yu Rao Design, synthesis, and biological evaluation of multiple targeting antimalarials Acta Pharmaceutica Sinica B Drug design Multiple targeting compounds Antimalarial inhibitors Mechanism of action Membrane proteins |
| title | Design, synthesis, and biological evaluation of multiple targeting antimalarials |
| title_full | Design, synthesis, and biological evaluation of multiple targeting antimalarials |
| title_fullStr | Design, synthesis, and biological evaluation of multiple targeting antimalarials |
| title_full_unstemmed | Design, synthesis, and biological evaluation of multiple targeting antimalarials |
| title_short | Design, synthesis, and biological evaluation of multiple targeting antimalarials |
| title_sort | design synthesis and biological evaluation of multiple targeting antimalarials |
| topic | Drug design Multiple targeting compounds Antimalarial inhibitors Mechanism of action Membrane proteins |
| url | http://www.sciencedirect.com/science/article/pii/S221138352100174X |
| work_keys_str_mv | AT yiqingyang designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT tongketang designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT xiaoluli designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT thomasmichel designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT liqinling designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT zhenghuihuang designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT maruthimulaka designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT yuewu designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT hongyinggao designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT liguowang designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT jingzhou designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT brigittemeunier designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT hangjunke designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT lubinjiang designsynthesisandbiologicalevaluationofmultipletargetingantimalarials AT yurao designsynthesisandbiologicalevaluationofmultipletargetingantimalarials |